WashUOncology
@washuonc
Official Account of the Division of Oncology at Washington University School of Medicine--Pioneering Treatments, Advancing Knowledge, Training Leaders
ID: 1618302895161544734
https://oncology.wustl.edu/ 25-01-2023 17:41:03
544 Tweet
551 Followers
308 Following
**HIV Hodgkin therapy ✅Brentuximab vedotin–AVD was highly active and had a tolerable adverse event rate in HIV-cHL ✅The complete reponse rate is encouraging From Lee Ratner WashUOncology and colleagues #nhlsm #lymsm WUSM Department of Medicine Test Account Siteman Cancer Center thelancet.com/journals/lanha…